Avalon GloboCare Appoints Dr. James L. Gajewski, Former Medical Director at M.D. Anderson Cancer Center, to Head Scientific and Clinical Advisory Board
August 14, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed James L....
Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy
August 07, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has...
Avalon GloboCare Appoints Prominent Life Science M&A Attorney Steven Sanders to the Board of Directors
July 31, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Steven...
Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences
July 18, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has...
Avalon GloboCare Appoints Senior Healthcare Executive William Stilley to Board of Directors
July 10, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, today announced that it has appointed William B. Stilley...
Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs
June 12, 2018 07:30 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has formed a joint...
Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors
June 04, 2018 07:00 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J, June 04, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Tevi...
Avalon GloboCare Provides First Quarter 2018 Business Update; Reports 365% Increase in Revenues and Progress Towards Commercialization of its Cell-Based Technologies
May 14, 2018 08:00 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a business...